Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01423487

Efficacy and Safety of Metformin in Preventing Patients With Risperidone From Weight Gain and Amenorrhea

Efficacy and Safety of Metformin in Preventing Patients With Risperidone From Weight Gain and Amenorrhea:a 24-week, Randomized, Placebo-controlled, Double-blind, Fixed-dose Study

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Central South University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Some previous studies has demonstrated that Metformin can improve the weight gain which caused by antipsychotics. An our study, which will be published, also found that Metformin can improve the amenorrhea for patients with antipsychotics, approximately 60% patients recovery period. So the present study was designed to investigate the efficacy and safety of Metformin in preventing patients with Risperidone from weight gain and amenorrhea.

Conditions

Interventions

TypeNameDescription
DRUGMetformin0.5g bid 26 weeks
OTHERStarch tablets0.5g bid 26 weeks

Timeline

Start date
2011-08-01
Primary completion
2013-02-01
Completion
2013-08-01
First posted
2011-08-26
Last updated
2012-08-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01423487. Inclusion in this directory is not an endorsement.